Ionis Pharmaceuticals and Arrowhead Pharmaceuticals have found a common cause amid their emerging rivalry. | Ionis ...
Envestnet Portfolio Solutions Inc. bought a new position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund bought 10,080 ...
The National Triglyceride Alliance (NTA) is proud to announce its official launch, marking a pivotal step in advancing ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Opko Health (OPK – Research Report), with a price ...
MedPage Today on MSN5d
STRIDE: Semaglutide Shows It Has Legs in Peripheral Artery DiseaseCHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...
In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Cue Biopharma (CUE – Research Report), with a price ...
Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.
GlaxoSmithKline has joined the ranks of drugmakers trying to develop new drugs for non-alcoholic steatohepatitis (NASH) – a condition with no approved therapies and a lengthy list of failed drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback